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due to their water equivalency (i.e. they cannot be differentiated 
from tissue), but accurate localization is necessary for comparison of 
measured dose to dose calculated on CT images. 
Materials and Methods: We constructed two mock PSDs with CT-radio-
opaque metal wire used in place of scintillating fibers. Each mock 
detector was constructed to the specifications of in-vivo PSDs being 
used at our institution and consisted of a 7 mm graphite spacer, 2 mm 
of radio-opaque wire coupled to a clear plastic optical fiber contained 
in black polyethylene jacketing. 2 mm spherical ceramic fiducials 
were attached at the end of the detector and to either side of the 
detector 1 cm distal to the wire as surrogates for calculating the 
location of the ‘sensitive volume’. The detectors were attached to an 
endorectal balloon which was subsequently inserted into an 
anthropomorphic prostate phantom and inflated. A CT scan (2.5 mm 
slice thickness, the same used when imaging in-vivo detectors in 
patients) of the phantom was then acquired, and the resulting images 
imported into the Pinnacle treatment planning system. A script then 
determined the location of the active volume by calculating a line 
between the center of the proximal fiducial and a point halfway 
between the two distal fiducials (i.e. the center of the optical fiber) 
and contouring 1 mm diameter circles around the line on slices 
containing the portion of the line between 8 mm and 10 mm. The 
locations of the resulting contours were compared to the location of 
the metal wire. This process was repeated ten times – removing and 
deflating the balloon, detaching the detectors, and then re-setting up 
the experiment completely each time. 
Results: The average deviation in the axial plane between the center 
of the contours and the center of the metal wire was 0.1 mm in the 
anterior direction (Figure 1). The root-mean-square deviation was 0.4 
mm. All contours were within 0.8 mm of the actual location. 13 out of 
20 measurements were localized to the correct axial slice, and the 
other 7 were one slice off. Axial discrepancies were considered more 
important than SI discrepancies because the dose gradient of patient 
treatment plans lies primarily along the AP direction. The direction 
and magnitude of the deviation from actual location for all 20 
measurements are shown in Figure 1. 
 
  
Conclusions: The methodology for contouring the sensitive volume of 
a scintillation detector was found to consistently produce contours in 
good agreement with the position of the detector’s sensitive volume. 
This method can be used to effectively localize the actual PSDs within 
an accuracy of less than 0.8 mm.  
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Purpose/Objective: Medical linear accelerators (linacs) capable of 
delivering flattening filter free (FFF) beams present a promising 
option for radiotherapy clinics due to potentially reduced treatment 
times and lower doses out of field. However, successful treatment 
outcome depends on the accuracy of the commissioning data loaded 
into treatment planning systems - especially for treatments involving 
small or composite fields. A comparison of beam data between 
dosimetry methods is therefore required to assess the uncertainties on 
dose estimates. Differences in response of different dosimetry 
methods, primarily due to energy dependence, have been discussed in 
the literature for conventional flattened (FF) beams. However, it is 
not obvious that the same differences apply in FFF beams. To assess 
this, we present measurements of central dosimetric parameters, 
obtained using three different dosimetry methods in FFF beams. 
Materials and Methods: Measurements were performed in water for a 
Varian TrueBeam not yet commissioned for FFF beams. The 
measurements concerned i) output factors, ii) TPR20:10 ratios, and iii) 
dose per pulse. Output factors and TPR20:10 measurements were 
acquired for 6 MV and 10 MV beams operated in FFF mode, using i) a 
fibre-coupled organic scintillator, ii) a PTW 60003 diamond detector 
and iii) an IBA CC13 ionization chamber. To accurately determine the 
increase in instantaneous dose rate when removing the flattening 
filter, the dose per pulse was measured using the fibre-coupled 
organic scintillator for FFF as well as FF beams. 
Results: The table shows measured output factors (mean ± 1 SD) 
obtained at 90 cm source to surface distance and 10 cm depth. 
Differences between detectors were significant for large fields, 
amounting to 3.2 % at the largest. Conversely, differences of up to 2.8 
% between the scintillator and diamond were seen for small fields. 
Measurements of TPR20:10 ratios were more consistent, agreeing to 
within 0.8 % for the three dosimetry methods. The measured dose per 
pulse was 2.7 times higher for 6 MV FFF than for 6 MV FF, and 4.6 
times higher for 10 MV FFF than for 10 MV FF, comparing well with 
literature values of FFF beam output (Int J Radiat Oncol Biol Phys 80, 
1228-1237, 2011). 
Conclusions: The presented measurements show that detector-
inherent differences in output factor measurements are also 
encountered in FFF beams. The over-response of diamonds has been 
discussed in the literature for FF beams (Phys Med Biol 57, 4461-4476, 
2012); similarly, differences between ionization chambers and 
scintillators have been reported for 6 MV large fields (Med Phys 38, 
2140-2150, 2011). We conclude that these findings also apply in FFF 
beams. However, the needed correction factors for ionization 
chambers and diamonds are larger for FFF beams due to the higher 
dose per pulse. To further assess dosimetric uncertainties, a logical 
next step would be to compare beam data for linacs situated at 
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Purpose/Objective: EBT2 and EBT3 radiochromic films are 
characterized by a high spatial resolution that can’t be matched by 
two-dimensional ion chamber or diode arrays. Thanks to this property 
they seem to be ideal dosimeters for the verification of TomoTherapy 
stereotactic body radiation therapy (SBRT) plans. Their response is 
degraded by two different sources: acquisition process related 
distortion; inherent dose sensitivity variations. Moreover this non-
uniformities convolve with the regular dose fluctuation pattern 
inherent to helical dose delivery. In this study a protocol that allows 
to reduce the spatial non-uniformity to a clinically acceptable level 
was investigated. 
Materials and Methods: Dose sensitivity variations was quantified for 
different film batches by delivering a uniform dose distribution with a 
standard linear accelerator. The frequency range that characterized 
noise bands was identified with a band-pass filter. 10 TomoTherapy 
SBRT plans were delivered on EBT2-3 films. Films were digitized with 
an Epson scanner and the resulting images were converted in net 
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optical density (OD). The optical density distributions were then 
corrected for the acquisition-related distortion by means of an 
algorithm available in literature. The dose fluctuation pattern 
inherent to helical TomoTherapy was then extracted by applying 
another band-pass filter. Finally, after the application of an OD-dose 
calibration, the dose distributions were filtered in order to reduce low 
and high frequency noise. For the selection of the most suitable filter 
various possibilities were tested, including the complete removal of 
the predetermined frequency range which characterizes the batch. 
The quality of the uniformity correction protocol was evaluated by 
comparing passing rates obtained with films and those achieved with 
PTW OCTAVIUS system. 
Results: The level of dose sensitivity variations depends on the 
specific batch [2-4] %. The frequency range seems to be similar for 
intra-batch films, while different for inter-batch films. The pure 
elimination of the band frequency range is not applicable. This is 
because the frequencies that characterized the dose sensitivity 
variations and those that characterized the dosimetric information are 
comparable. The best low and high frequency noise reduction is 
obtained by applying the wavelet filtering method and separately 
adding the dose fluctuation pattern inherent to helical TomoTherapy 
to the SBRT dose distribution. Using a gamma function 3mm-3%, 
agreement between planned and measured dose distributions was 
found to be always better then 90% only if the correction protocol was 
applied. 
  
Conclusions: Radio chromicfilms response, if corrected by our 
protocol, can be used for the verification of TomoTherapy SBRT plans 
where high spatial resolution is needed.  
 
 POSTER: PHYSICS TRACK: DOSE MEASUREMENTS  
  
PO-0771   
A reliable algorithm for calculating 3D patient dose based on 
measured point doses in a QA phantom 
A. Gustafsson1, P. Münger2, T. Matzen2, G. Nilsson2 
1Cureos AB, Uppsala, Sweden  
2ScandiDos AB, Uppsala, Sweden  
 
Purpose/Objective: QA phantoms for dose verification of complex 
radiation treatments such as IMRT and VMAT are currently in 
widespread use. By monitoring beam or control point dose in a large 
number of small detectors distributed within the QA phantom and 
comparing measured dose with TPS calculated dose in the QA 
phantom, accurate confirmation of spatial deviations between 
planned and delivered dose can be obtained.The clinical 
interpretation of deviations is however limited by the fact that doses 
are being compared in the QA phantom. To facilitate evaluation of the 
clinical impact of observed dose deviations, the TPS calculated dose 
in the patient should ideally be compared with the patient dose 
distribution corresponding to the measured doses in the QA phantom. 
Materials and Methods: This work describes the development and 
validation of a novel technique for accurate and reliable 3D photon 
dose calculation in a patient volume based on detector dose 
measurements in a QA phantom of arbitrary material. The technique 
consists of two steps: 
1. For the given beam quality and accounting for the phantom 
composition, estimate the 2D energy fluence distribution that best 
represents the measured detector doses in the QA phantom. 
2. Apply the obtained energy fluence and the given beam quality in a 
3D dose calculation for the patient volume. 
The estiated energy fluence distribution represents the radiant energy 
resulting from modulation and collimation in the treatment 
head,independent of dose calculation geometry. Presence or absence 
of flattening filter is automatically accounted for. 
The energy fluence estimation is formulated as a linear optimization 
problem, where the objective is to minimize the integral fluence 
given that the calculated phantom dose in every accountable detector 
position is greater than or equal to the measured dose. This 
formulation is guaranteed to have a feasible solution and the 
calculated-to-measured dose deviation is implicitly minimized through 
the integral fluence objective. 
Results: The technique has been applied to both MLC collimated IMRT 
fields with non-uniform energy fluence and VMAT fields where patient 
dose is calculated for the individual control points and subsequently 
added to yield a total 3D dose. The technique is consistently able to 
reproduce reference absolute dose results within 3% and 3 or 6 mm, 
depending on the local spatial resolution of the detector grid. 
Conclusions: A technique for calculating 3D photon dose in the 
patient volume based on measured detector doses in a QA phantom 
has been implemented. The technique is applicable to complex 
treatments such as IMRT and VMAT and has been shown to accurately 
and reliably obtain 3D patient dose distributions that can be 
immediately compared with 3D dose distributions planned and 
calculated with a regular treatment planning system. 
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Purpose/Objective: Treatment planning system (TPS) capabilities 
should beverified in a real 3D situation with rigorous procedures, both 
for static and rotational modulated fields. 
The American Association of Physicists in Medicine TaskGroup 119 
(TG119) proposed a water equivalent square slab phantom (30x30x15 
cm3) with four IMRT tests: mock prostate (MP), head-and-neck (HN), 
C-shaped target (CS), and Multi Target (MT). Each test was developed 
to assess the overall accuracy of planning and delivery of IMRT 
treatments. The test suite with DICOM-RT images and structures can 
be downloaded from the AAPM web-site. TG119 defines also beams 
arrangement, IMRT goals, and methods for analyzing the dosimetric 
results on their phantom. The AAPM phantom is cheap and easily 
reproducible in every department, but it allows only single point or 
single planar measurements. In order to apply the TG119 report in a 
more sophisticated situation we used a 3D dosimetric phantom and all 
tests were re-optimized to satisfy all defined goals. 
Materials and Methods: TG119 was pre-emptively used 'as is' in order 
to test the capability of our clinical arrangement. After this, TG119 
structures were superimposed on the CT images of a cylindrical PMMA 
phantom surrounding two orthogonal matrix with 1069 total diodes 
(Delta4 - 3D dosephantom; Scandidos, SWE). TG119 tests were thus 
calculated and optimized using a Monte Carlo TPS (Monaco3.20; 
Elekta, SWE) for 6 and 10 MV photon beams, with IMRT and VMAT 
techniques, following the plan proposed goals. Delta4 phantom was 
used in order to carryout comparison between measured and planned 
3D absolute dose distributions. A 3%, 3mm with a 10% threshold 
(defined by the isodose line representing 10% of maximum dose) 
gamma test was performed for plans analysis.  
Results: Goals proposed in TG119 were satisfied for each planand 
technique. For all IMRT plans gamma values were lower than 1 for 
more than 98.3% of compared point, except for the CS plan delivered 
with 6 MV (Fig.1), where gamma analysis was satisfied for 90.5% of 
total points. The mean percentage of passing points for all energies 
was 98.4 ± 3.3%. Preliminary results were obtained for VMAT cases, 
with a mean percentage of 88.5 ± 8.4%. VMAT is at present under 
refinement and better results are expected after the optimisation of 
the Monte Carlo model. 
 
 
